AZ-Biopharm is present at the International Cannabis Business Conference (ICBC) B2B.

AZ-Biopharm is present at the International Cannabis Business Conference (ICBC) B2B.

This conference will take place on August 26-27, 2021 at the Vienna House Andel’s Berlin,
Landsberger Allee 106, 10369 Berlin (https://internationalcbc.com/berlin/).

(more…)

Nitroso-amine screening method established at AZ-Biopharm for 12 N-nitrosamines.

At AZ-Biopharm we established, after the development and validation of a GC-MS and an even more sensitive UHPLC-MSMS method for the determination of N-nitroso-dimethylamine (NDMA) in drugs and in APIs, a screening method for 12 nitrosamines.

(more…)

AZ Biopharm has started vaccination of personnel against Covid-19

AZ-Biopharm has early on implemented measures to protect our personnel from Covid-19 infections.

(more…)

AZ-Biopharm invests further in lab infrastructure.

AZ-Biopharm invested more than 50k€ and acquired an emergency power supply to secure the safe storage of our customers samples.

(more…)

AZ Biopharm increases the rate of strokes

After purchasing and installing 3 new release systems last year, AZ Biopharm recently installed 6 more in-vitro release systems.

(more…)

Nitrosamines in metformin medicines

Dear Mms and Sirs,

You are sure to be informed about it: Nitrosamines in medicinal products – after valsartan, ranitidine now metformin! Press release from BfArM as of 10/16/2020: The EU supervisory authorities request nitrosamine tests on medicinal products containing metformin. “The European Medicines Agency EMA and the competent national authorities in the EU will contact all marketing authorization holders of metformin-containing medicinal products and ask them to test all metformin-containing finished medicinal products for the presence of nitrosamines before they are released on the market.

(more…)

AZ-Biopharm will participate and present at the 13th EBF Open Symposium in Cyberspace

AZ-Biopharm will participate on the N° 13 EBF Open Symposium – “From Cyberspace – Staying Connected”, 17-20 November 2020.

(more…)

Nitrosamines in medicinal products – After valsartan, ranitidine now metformin!

Press release BfArM October 16, 2020

The EU supervisory authorities require nitrosamine tests on medicinal products containing metformin.

„The European Medicines Agency (EMA) and the responsible national authorities in the EU will contact all marketing authorization holders of metformin-containing medicinal products and ask them to test all metformin-containing finished medicinal products for the presence of nitrosamines before they are released to the market.

(more…)

Covid-19 outbreak – AZ-Biopharm can support you in drug manufacturing, QC and drug development

Meanwhile almost all countries are affected by the virus spread putting many especially elderly people on high risk to die. And although in a few countries one observes that the infection rates are slowing down and scientists around the world are doing a great job to discover a vaccine, there is no mid-term solution for an effective vaccine on the horizon.

(more…)

COVID-19 VIRUS OUTBREAK

With the outbreak of the Covid 19 virus, we are now facing a pandemic in Europe. At AZ-Biopharm we have taken strict measures in accordance with our social and business responsibility. In the first place, of course, is the general public health of our employees, partners and visitors. As an active and system-critical actor in public health care, AZ-BIOPHARM has taken the following measures to contain the spread of viruses and the safety of everyone:

(more…)